Peter Goadsby - Publications#
Peter Goadsby has 1,970 published papers, books/chapters, abstracts; Google Scholar H-index 147; citations 92620.
Major publications in the last five years:
1. Hu B, Akerman S, Goadsby PJ. Characterization of opioidergic mechanisms related to the anti‐migraine effect of vagus nerve stimulation. Neuropharmacology. 2021;195:108375.
2. Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM, et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. The Lancet. 2021;397:51-60.
3. Schankin CS, Maniyar F, Chou DE, Eller M, Sprenger T, Goadsby PJ. Structural and functional footprint of visual snow syndrome. Brain. 2020;143:1106-13.
4. Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine. New England Journal of Medicine. 2019;381:142-9.
5. Hoffmann J, Storer RJ, Park JW, Goadsby PJ. N-Methyl-D-aspartate receptor open-channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats. European Journal of Neuroscience. 2019;50:2847-59.
6. Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 2019;142:1894-904.
7. Goadsby PJ, Sahai-Srivastava S, Kezirian EJ, Calhoun AH, Matthews DC, McAllister PJ, et al. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind randomised controlled trial. Lancet Neurology. 2019;18:1081-90.
8. Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, et al. Trial of Galcanezumab in Prevention of Episodic Cluster Headache. New England Journal of Medicine. 2019;381:132-41.
9. Akerman S, Karsan N, Bose P, Hoffmann JR, Holland PR, Romero-Reyes M, et al. Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity. Brain. 2019;142:103-19.
10. Goadsby PJ, Reuter U, Hallstrom Y, Broessner G, Bonner JH, Zhang F, et al. A controlled trial of erenumab for episodic migraine. New England Journal of Medicine. 2017;377:2123-32.
